Pleural complications and chest tube follow-up in patients with COVID-19
dc.authorid | Batıhan, Güntuğ/0000-0001-5258-2856 | |
dc.authorid | Yazgan, Serkan/0000-0001-9763-6336 | |
dc.authorid | Kirakli, Cenk/0000-0001-6013-7330 | |
dc.authorwosid | Batıhan, Güntuğ/AAS-4733-2020 | |
dc.authorwosid | Yazgan, Serkan/GSO-1911-2022 | |
dc.authorwosid | Kirakli, Cenk/AAE-2202-2020 | |
dc.contributor.author | Ceylan, Kenan Can | |
dc.contributor.author | Batıhan, Güntuğ | |
dc.contributor.author | Yazgan, Serkan | |
dc.contributor.author | Gürsoy, Soner | |
dc.contributor.author | Kıraklı, Sami Cenk | |
dc.contributor.author | Ataman, Sena | |
dc.date.accessioned | 2023-03-22T19:47:33Z | |
dc.date.available | 2023-03-22T19:47:33Z | |
dc.date.issued | 2021 | |
dc.department | Belirlenecek | en_US |
dc.description.abstract | Introduction: It was reported that the SARS-CoV-2 virus primarily affects the lower respiratory system and various pleural complications may accompany coronavirus disease 2019 (COVID-19). Aims and objectives: We aimed to present the characteristics of patients who underwent a chest tube insertion due to pleural complications during COVID-19 disease and the technique we developed to minimize possible contamination from the underwater seal bottle in these patients. Methods: We retrospectively examined the characteristics of patients who developed pleural complications during COVID-19 disease in our hospital between March 11 and May 15, 2020. Results: Between March 11 and May 15, 2020, a total of 342 patients were hospitalized with the diagnosis of COVID-19. Tube thoracostomy was performed in 13 (%3.8) of these patients due to pleural complications. Indications for chest tube placement were: Pneumothorax in six (%46.1) patients, pleural effusion in three (%23) patients, empyema in three (%23) patients, and hemothorax in one patient (%7.6). A high-efficiency particulate air (HEPA) viral filter mounted two bottle technique was used in the follow-up of chest drains | en_US |
dc.identifier.doi | 10.1183/13993003.congress-2021.PA438 | |
dc.identifier.issn | 0903-1936 | |
dc.identifier.issn | 1399-3003 | |
dc.identifier.uri | https://doi.org/10.1183/13993003.congress-2021.PA438 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14034/764 | |
dc.identifier.volume | 58 | en_US |
dc.identifier.wos | WOS:000747452105344 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | European Respiratory Soc Journals Ltd | en_US |
dc.relation.journal | European Respiratory Journal | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Covid-19 | en_US |
dc.subject | Pleura | en_US |
dc.subject | Treatments | en_US |
dc.title | Pleural complications and chest tube follow-up in patients with COVID-19 | en_US |
dc.type | Conference Object | en_US |